Back

Effects of SGLT2 inhibition on cardiac remodeling and heart failure development in rats with aortic stenosis

26 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: From bedside to bench: unravelling the mechanisms of valvular heart disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Katashi Okoshi

UNESP- Medical School, Botucatu (Brazil)

7 More presentations in this session

Presentation thumbnail
Introducing a novel ex-vivo calcification model for human aortic valves
Ms M. El Ouraoui (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Spatial transcriptomic analysis identifies a border zone with localized expression of brain natriuretic peptide in the inferobasal region of the left ventricle in patients with mitral valve prolapse
Doctor J. Boeckel (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Differential microRNA expression in atrial vs. ventricular functional tricuspid regurgitation. New insights into TR pathophysiology
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Enhanced expression of iNOS is associated with aortic valve stenosis in patients with bicuspid aortic valve
Doctor Y. Kashima (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
From bedside to bench: unravelling the mechanisms of valvular heart disease

The Event

Event poster

ESC Congress 2023

26 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of empagliflozin on myocardial transcriptome in rats with aortic stenosis-induced heart failure
thumbnail
Congress Presentation
Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure
thumbnail
Congress Presentation
Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources